Robert Christopher Andrade, executive of Fennec Pharmaceuticals Inc. (TSX:FRX), picked up 128,772 Common Shares at an average of $10.65 — a $1.4M buy on Aug 28, 2026.
The purchase grows their position by 116%. They still hold 239,603 shares — a stake worth roughly $4.1M at today's price.
FRX shares are trading around $17.00, up 0.0% in the latest session, up 27% over the past three months, and up 63% this year. The stock has ranged from $8.10 to $17.63 over the past 52 weeks and sits within 4% of that high.
Growing a stake by 116% isn't pocket change — this looks like a bet on the company's next chapter.
